Argentine-developed COVID-19 vax to start phase 1 trials
The first vaccine against COVID-19 developed in Argentina is to be tested on humans during phase 1 trials, it was announced Wednesday in Buenos Aires.
The first vaccine against COVID-19 developed in Argentina is to be tested on humans during phase 1 trials, it was announced Wednesday in Buenos Aires.